AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E677-E685, 2004. First published May 18, 2004; doi:10.1152/ajpendo.00009.2004
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/4/E677    most recent
00009.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haugaard, S. B.
Right arrow Articles by Madsbad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugaard, S. B.
Right arrow Articles by Madsbad, S.

Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells

Steen B. Haugaard,1,2,3 Ove Andersen,1,3 Heidi Storgaard,4 Flemming Dela,5,6 Jens Juul Holst,6 Johan Iversen,1 Jens Ole Nielsen,1 and Sten Madsbad2

1Department of Infectious Diseases, 2Department of Endocrinology and Internal Medicine, and 3Clinical Trial Unit, Hvidovre University Hospital, DK 2650 Copenhagen; 4Steno Diabetes Center, Gentofte, DK-2820 Copenhagen; and 5Copenhagen Muscle Research Centre and 6Department of Medical Physiology, The Panum Institute, University of Copenhagen, DK 2200 Copenhagen, Denmark

Submitted 7 January 2004 ; accepted in final form 6 May 2004

We examined whether plasma concentrations of nonglucose insulin secretagogues are associated with prehepatic insulin secretion rates (ISR) in nondiabetic, insulin-resistant, human immunodeficiency virus (HIV)-infected, lipodystrophic patients (LIPO). Additionally, the negative feedback of insulin on ISR was evaluated. ISR were estimated by deconvolution of plasma C-peptide concentrations during fasting (basal) and during the last 30 min of a 120-min euglycemic insulin clamp (40 mU·m–2·min–1). Eighteen normoglycemic LIPO were compared with 25 normoglycemic HIV-infected patients without lipodystrophy (controls). Thirty minutes before start of the clamp, a bolus of glucose was injected intravenously to stimulate endogenous insulin secretion. Insulin sensitivity index (SiRd) was estimated from glucose tracer analysis. LIPO displayed increased basal ISR (69%), clamp ISR (114%), basal insulin (130%), and clamp insulin (32%), all P ≤ 0.001, whereas SiRd was decreased (57%, P < 0.001). In LIPO, ISRbasal correlated significantly with basal insulin, alanine, and glucagon (all r > 0.65, P < 0.01), but not with glucose. In control subjects, ISRbasal correlated significantly with insulin, glucagon, and glucose (all r > 0.41, P < 0.05), but not with alanine. In LIPO, ISRclamp correlated significantly with clamp free fatty acids (FFA), alanine, triglyceride, and glucagon (all r > 0.51, P < 0.05). In control subjects, ISRclamp correlated with clamp triglyceride (r = 0.45, P < 0.05). Paradoxically, in LIPO, ISRclamp correlated positively with clamp insulin (r = 0.68, P < 0.01), which suggests an absent negative feedback of insulin on ISR. Our data support evidence that lipodystrophic, nondiabetic, HIV-infected patients exhibit increased ISR, which can be partially explained by an impaired negative feedback of insulin on {beta}-cells and an increased stimulation of ISR by FFA, alanine, triglyceride, and glucagon.

human immunodeficiency virus; nonglucose insulin secretagogues



Address for reprint requests and other correspondence: S. B. Haugaard, Clinical Trial Unit 136, Hvidovre Univ. Hospital, DK 2650 Hvidovre, Copenhagen, Denmark (E-mail: sbhau{at}dadlnet.dk)




This article has been cited by other articles:


Home page
J. Nutr.Home page
C. Hoppe, G. S. Andersen, S. Jacobsen, C. Molgaard, H. Friis, P. T. Sangild, and K. F. Michaelsen
The Use of Whey or Skimmed Milk Powder in Fortified Blended Foods for Vulnerable Groups
J. Nutr., January 1, 2008; 138(1): 145S - 161S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.